Endocrine Reviews Editorial Team Editor-in-Chief Editor Drucker DanielDaniel J. Drucker, MD University of Toronto and Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital Toronto, Ontario, Canada Dr. Drucker received his MD (1980) from and is currently professor of medicine at the University of Toronto. He holds the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and is a senior scientist at the Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital. While maintaining a long-standing interest in thyroid disease (Mythyroid website), his laboratory studies the molecular biology and physiology of gut hormones with a focus on the glucagon-like peptides. Dr. Drucker’s scientific studies identified multiple novel mechanisms of hormone action, enabling development of new drug classes for diabetes, obesity, and intestinal failure. He has received numerous awards from learned societies for his discoveries, including the Banting Award from the American Diabetes Association, the Claude Bernard Award from the European Foundation for the Study of Diabetes, the Manpei Suzuki International Prize, the Rolf Luft Award from the Karolinska Institute, and the Harrington Prize for Innovation in Medicine. He has also been elected a Fellow of the Royal Society, London.
Associate Editors Editor Ahima RexRexford Ahima, MD, PhD Johns Hopkins University Baltimore, Maryland, USA Dr. Ahima received his MD from the University of Ghana and PhD from Tulane University in New Orleans. He received his internship and residency training in internal medicine at Jacobi Medical Center and Weiler Hospital, Albert Einstein College of Medicine, and his clinical and postdoctoral research fellowship in endocrinology, diabetes, and metabolism at the Beth Israel Deaconess Medical Center and Harvard Medical School. Dr. Ahima is currently professor of medicine, public health, and nursing, Bloomberg Distinguished Professor of Diabetes, and director of the Division of Endocrinology, Diabetes, and Metabolism at the Johns Hopkins University. His research focuses on CNS and peripheral actions of adipokines and other circulating factors in energy homeostasis, and glucose and lipid metabolism. He is a member of the American Society of Clinical Investigation and the Association of American Physicians, as well as a fellow of the American Association for the Advancement of Science, American College of Physicians, and the Obesity Society.
Editor Camper SallySally A. Camper, PhD University of Michigan Medical School Ann Arbor, Michigan, USA Dr. Camper received her PhD in biochemistry from Michigan State University in 1983 and completed postdoctoral training at Princeton University in 1988. She holds the Margery W. Shaw Distinguished University Professorship in Human Genetics and is also a professor of internal medicine at University of Michigan Medical School in Ann Arbor. Her current research focuses on the development and function of the hypothalamic-pituitary axis in health and disease states. Dr. Camper uses genomic approaches to identify genetic causes of hypopituitarism and genetic engineering in mice to understand disease pathophysiology. Her research accomplishments and devotion to mentoring trainees have been recognized by the University of Michigan, the Endocrine Society, the American Association for the Advancement of Science, the March of Dimes, and the National Institutes of Health.
Editor Dokras AnujaAnuja Dokras, MD, DPhil University of Pennsylvania Philadelphia, Pennsylvania, USA Dr. Dokras received her medical degree from the University of Bombay, India. As a Rhodes scholar she obtained a DPhil from University of Oxford, UK. She completed a residency in obstetrics and gynecology and fellowship training in reproductive endocrinology and infertility at Yale University. Dr. Dokras is currently professor of obstetrics and gynecology at the University of Pennsylvania, where she served as the medical director of the IVF program at Penn Fertility Care (2007-2013) and continues to direct the Preimplantation Genetic Testing Program and the reproductive surgical facilities. She is also the director of the multi-disciplinary Penn Polycystic Ovary Syndrome (PCOS) Center. Dr. Dokras's research program focuses on understanding the determinants of cardiovascular risk associated with PCOS at both the cellular and population level. Other areas of research include the impact of clinical interventions on metabolic risk, pregnancy, health-related quality of life, anxiety, and mood disorders in women with PCOS. Her research has been funded by the National Institutes of Health, the American Society of Reproductive Medicine, and the Reproductive Scientist Development Program. She is the past president of the Androgen Excess (AE)-PCOS Society (2014-2016), an international society focused on supporting education, research, and patient awareness related to all aspects of androgen excess disorders.
Editor Gloyn AnnaAnna L. Gloyn, DPhil University of Oxford Oxford, United Kingdom Professor Gloyn is Professor of Molecular Genetics & Metabolism and a Wellcome Trust Senior Fellow in Basic Biomedical Science based jointly at the Oxford Centre for Diabetes, Endocrinology, and Metabolism and the Wellcome Centre for Human Genetics at the University of Oxford. She completed her DPhil on the molecular genetics of type 2 diabetes under the supervision of the late Professor Robert Turner at the University of Oxford before taking up post-doctoral training under the mentorship of professors Andrew Hattersley and Sian Ellard at the University of Exeter and Professor Franz Matschinksy at the University of Pennsylvania. Professor Gloyn’s research is focused on using naturally occurring mutations in humans as tools to identity critical regulatory pathways and insights into normal physiology. Her work has been recognized both nationally and internationally. She is a recipient of a European Association for the Study of Diabetes (EASD) Rising Star Award (2005), the R.D. Lawrence Named Lecturer (Diabetes UK Annual Professional Conference 2009), the G.B. Morgagni Prize (2014), and the EASD Minkowski Prize (2014).
Editor Li XiaoyingXiaoying Li, MD, PhD Zhongshan Hospital, Fudan University Shanghai, China Dr. Li received his MD from Hengyang Medical University and PhD from Shanghai Second Medical University (currently Shanghai Jiaotong University Medical School). He is currently professor of medicine and director of the Department of Endocrinology and Metabolism at the Zhongshan Hospital Fudan University. Dr. Li was trained as an endocrinologist at Chongqing Xinqiao Hospital and as a postdoctoral fellow at Baylor College of Medicine and McGill University from 1998–2003. His research focuses on non-alcoholic fatty liver diseases and insulin resistance in type 2 diabetes. He is a member of the Chinese Diabetes Society and the International Diabetes Federation. He has published more than 90 papers in peer-reviewed journals.
Editor Mendonca BereniceBerenice B. Mendonca, MD University of São Paulo São Paulo, Brazil Dr. Mendonca received her MD in 1973 from Faculdade de Medicina do Triângulo Mineiro in Brazil. In 1984, she completed her research fellowship in endocrinology at the University of São Paulo School of Medicine, where she developed all her scientific achievements. Dr. Mendonca’s group has made major contributions to the understanding of the pathophysiology of endocrine tumors, congenital adrenal hyperplasia, hyper- and hypofunction of the adrenals, endocrine hypertension, growth hormone deficiency, disorders of puberty, and mainly disorders of sex development. She has brought a new insight to the diagnosis and treatment of endocrine diseases by merging the clinical aspects observed in the course of her practice with genetics and molecular biology techniques. Dr. Mendonca is currently the Full Professor of the Discipline of Endocrinology at University of São Paulo and head of the Laboratory of Hormones and Molecular Genetics, LIM/42. Her work has been recognized by several learned societies. She was the recipient of the 2009 Brazilian Society for Endocrinology and Metabolism Award, the 2012 Latin American Society for Pediatric Endocrinology Award, and the 2013 Endocrine Society Inaugural International Excellence in Endocrinology Award. She was the Clinical Endocrinology Trust Visiting Professor in the United Kingdom in 2012.
Editor Sasano HironobuHironobu Sasano, MD, PhD Tohoku University School of Medicine Sendai, Japan Professor Sasano has been involved in the translational research of various human diseases including adrenocortical disorders for nearly 30 years and has published numerous peer reviewed articles. In particular, his groups have established the details of in situ steroid biosynthesis and metabolism in human disorders, which resulted in the detailed endocrine-pathology correlation of various adrenocortical disorders as well as in establishment of intracrinology or intracrine estrogen production in human estrogen-dependent neoplasms such as breast cancer, also serving as the basis of aromatase inhibitor therapy currently employed as the gold standard of endocrine therapy of hormone-dependent post-menopausal women with breast cancer. He graduated from Tohoku University School of Medicine, Sendai, Japan, in 1982. His postgraduate training included clinical and research fellowships at New York Hospital, the Cornell Medical Center, as a Fulbright Scholar, and as a pathology resident at the George Washington University Medical Center and Armed Forces Institute of Pathology, in Washington, D.C. Professor Sasano is a board certified pathologist in both Japan and the United States.
Editor Sims NatalieNatalie A. Sims, PhD St. Vincent’s Institute and The University of Melbourne Fitzroy, Australia Dr. Sims directs the Bone Cell Biology and Disease Unit at St. Vincent’s Institute and is an associate professor at The University of Melbourne. She completed her PhD at the University of Adelaide in 1995, followed by postdoctoral work at the Garvan Institute and Yale School of Medicine. Her laboratory studies the cellular interactions responsible for development, maintenance, and strengthening of the skeleton and has defined the roles of a number of key pathways, including the IL-6 cytokine family cytokines and estrogen receptor isoforms in bone through the use of genetically altered mouse models and in vitro systems. Dr. Sims’ work has been recognized by awards from the American Society of Bone and Mineral Research Fuller Albright Award (2010) and the International Bone and Mineral Society Herbert A Fleisch Award (2013).
Editor Steinberg GregoryGregory R. Steinberg, PhD McMaster University Hamilton, Ontario, Canada Dr. Steinberg received his PhD in 2002 and is a professor of medicine at McMaster University, where he holds a Canada Research Chair and a J. Bruce Duncan Endowed Chair in Metabolic Diseases. His research studies cellular energy sensing mechanisms and how endocrine factors, lipid metabolism, and insulin sensitivity are linked and contribute to the development of obesity, type 2 diabetes, and cardiovascular disease. His scientific contributions have been recognized by the Endocrine Society, the American Diabetes Association, Diabetes Canada, and the Canadian Institutes of Health Research, each of which has presented him with outstanding scientific achievement awards.
Disclosure Information for the Editor-in-Chief and Associate Editors
Publisher Richard T. O’Grady, PhD
Executive Editor Timothy M. Beardsley, DPhil
Acquisitions Editor Caitlin R. Ondracek, PhD
|
京公网安备 11010802027423号